CALR and heart failure: While overexpression of calreticulin improved cardiomyocyte function in CardiacCRT+ hearts, these hearts paradoxically feature severe cardiac pathology characterized by fibrosis, irregular ECG and heart failure, (S1 Fig) [16, 17].